Reporting from the UK: Skin of Color Has More Adverse Events From Sclerotherapy
Patients with skin of color may experience more adverse events from sclerotherapy, according to a study published online July 26 in the Journal of the American Academy of Dermatology.
Michelle Lazar, from the Boston University School of Medicine, and colleagues characterized the incidence of common adverse events following sclerotherapy in various Fitzpatrick Skin Types. The analysis included data from 134 patient visits for sclerotherapy (treated with 0.5 to 1 percent Polidocanol).
Source: Advances and More licensed by HealthDay
